Nuwellis Inc (NUWE) Stock Price, Quote & News

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. wa...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 345 4200

Website: www.nuwellis.com

Address:

12988 Valley View Road, Eden Prairie, United States

ValuePrince Sep. 13 at 4:47 AM

$NUWE ;

0 · Reply

done84 Sep. 12 at 2:42 AM

$NUWE just delist this scam finally!

0 · Reply

TheRipple Sep. 11 at 8:13 PM

$NUWE This is getting good.

0 · Reply

TALENT_ON_LOAN_FROM_GOD Sep. 11 at 5:30 PM

$BDRX $CNSY $NUWE GENIUS 🤡🤡🤡

0 · Reply

Dominicstocks Sep. 11 at 3:11 PM

$NUWE

0 · Reply

thomasirons Sep. 11 at 2:14 PM

$NUWE By not ANOTHER REVERSE SPLIT?.....It would give room for more Shorting.

0 · Reply

Smeagol_the_Trader Sep. 10 at 9:05 PM

$NUWE just patiently loading my position also in $VBIO loading my beautiful bag , lets see which one beat the other in therms of profit %.

0 · Reply

bazooka007 Sep. 10 at 5:53 PM

$NUWE 0,80+ eod and i would be a lucky man

1 · Reply

TheRipple Sep. 10 at 1:15 PM

$NUWE

0 · Reply

Scamstock Sep. 10 at 12:29 PM

$NUWE

0 · Reply

Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins

2026-08-25T12:40:23.000Z - 19 days ago

Nuwellis, Atrility Medical announce AtriAmp co-promotion and distribution pact

Aug 25, 2026, 8:30 AM EDT - 19 days ago

Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical

Aug 25, 2026, 8:00 AM EDT - 19 days ago

Nuwellis Slides: Investor presentation

2026-08-18T20:45:10.000Z - 25 days ago

Nuwellis files to sell 1.35M shares of common stock for holders

Aug 18, 2026, 8:00 AM EDT - 26 days ago

Nuwellis Registration statement: Registration filing

Aug 13, 2026, 9:00 AM EDT - 4 weeks ago

Nuwellis Earnings Call Transcript: Q2 2026

Aug 13, 2026, 9:00 AM EDT - 4 weeks ago

Nuwellis Earnings release: Q2 2026

Aug 13, 2026, 9:00 AM EDT - 4 weeks ago

Nuwellis Quarterly report: Q2 2026

Aug 13, 2026, 8:00 AM EDT - 4 weeks ago

Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin

Aug 6, 2026, 8:30 AM EDT - 5 weeks ago

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

Aug 4, 2026, 8:30 AM EDT - 5 weeks ago

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

2026-07-31T13:21:06.000Z - 6 weeks ago

Nuwellis prices $3.4M at-the-market offering at $2.59 per share

Jul 31, 2026, 8:39 AM EDT - 6 weeks ago

Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

2026-07-30T13:17:04.000Z - 6 weeks ago

Why Is Penny Stock Nuwellis (NUWE) Up Today?

Jul 30, 2026, 8:00 AM EDT - 6 weeks ago

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy

Jul 28, 2026, 8:00 AM EDT - 6 weeks ago

Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin

Jul 27, 2026, 8:30 AM EDT - 6 weeks ago

Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth

2026-07-16T12:35:27.000Z - 1 month ago

Nuwellis awarded U.S. patent for Dual Lumen Catheter

Jul 16, 2026, 8:30 AM EDT - 1 month ago

Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies

Jul 7, 2026, 8:00 AM EDT - 2 months ago

Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026

Jul 7, 2026, 8:00 AM EDT - 2 months ago

Nuwellis Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 2 months ago

Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)

Jun 26, 2026, 8:00 AM EDT - 2 months ago

Nuwellis Proxy statement: Proxy filing

2026-06-25T23:50:12.000Z - 2 months ago

Nuwellis Inc trading halted, news pending

Jun 25, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations

Jun 24, 2026, 8:30 AM EDT - 2 months ago

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

2026-06-18T12:51:14.000Z - 2 months ago

Nuwellis highlights clinical utility of its Aquadex SmartFlow system

Jun 18, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

2026-06-16T12:50:42.000Z - 2 months ago

Nuwellis CEO transition to transition out of role, Mike McCormick to succeed

Jun 16, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Appoints Mike McCormick as Chief Executive Officer

2026-06-10T12:50:10.000Z - 3 months ago

Nuwellis expands collaboration with South Carolina healthcare system

Jun 10, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children's Hospitals

Jun 8, 2026, 9:46 PM EDT - 3 months ago

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

2026-06-05T12:56:35.000Z - 3 months ago

Nuwellis 20M share secondary priced at 30c

Jun 5, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Announces Pricing of $6 Million Public Offering

Jun 4, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Registration statement: Registration filing

Jun 2, 2026, 7:00 AM EDT - 3 months ago

Nuwellis Slides: Investor presentation

May 29, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Registration statement: Registration filing

2026-05-22T21:15:44.000Z - 3 months ago

Nuwellis files to sell 4.85M shares of common stock, warrants

May 22, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Registration statement: Registration filing

2026-05-14T14:09:24.000Z - 4 months ago

Nuwellis completes Aquadex SmartFlow System pre-submission meeting with the FDA

May 14, 2026, 8:30 AM EDT - 4 months ago

Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label

May 12, 2026, 9:00 AM EDT - 4 months ago

Nuwellis Earnings Call Transcript: Q1 2026

May 12, 2026, 9:00 AM EDT - 4 months ago

Nuwellis Earnings release: Q1 2026

May 12, 2026, 9:00 AM EDT - 4 months ago

Nuwellis Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 4 months ago

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

May 5, 2026, 8:00 AM EDT - 4 months ago

Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

Apr 29, 2026, 8:30 AM EDT - 4 months ago

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

2026-04-28T13:19:54.000Z - 4 months ago

Nuwellis gets notice of allowance from USPTO for lumen midline catheter

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Apr 23, 2026, 8:30 AM EDT - 4 months ago

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

Apr 21, 2026, 8:30 AM EDT - 4 months ago

Nuwellis Announces Aquadex Software Update

2026-04-16T12:51:56.000Z - 5 months ago

Nuwellis announces return of three former team members

Apr 16, 2026, 8:30 AM EDT - 5 months ago

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

Apr 9, 2026, 8:30 AM EDT - 5 months ago

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

2026-04-07T13:45:21.000Z - 5 months ago

Nuwellis expands commercial footprint with new South Texas territory

Apr 7, 2026, 8:30 AM EDT - 5 months ago

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

Apr 6, 2026, 8:00 AM EDT - 5 months ago

Nuwellis Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 5 months ago

Nuwellis Proxy statement: Proxy filing

Mar 31, 2026, 8:30 AM EDT - 5 months ago

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

2026-03-17T12:27:39.000Z - 6 months ago

Nuwellis completes acquisition of Rendiatech

Mar 17, 2026, 8:00 AM EDT - 6 months ago

Nuwellis Completes Acquisition of Rendiatech

Mar 10, 2026, 9:00 AM EDT - 6 months ago

Nuwellis Earnings Call Transcript: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 6 months ago

Nuwellis Earnings release: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 6 months ago

Nuwellis Annual report: Q4 2025

2026-03-10T12:21:07.000Z - 6 months ago

Nuwellis reports Q4 EPS ($1.50) vs ($18.30) last year

Mar 10, 2026, 8:15 AM EDT - 6 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

2026-03-05T13:26:40.000Z - 6 months ago

Nuwellis appoints Goldstein as Director of Clinical Strategy

Mar 5, 2026, 8:00 AM EST - 6 months ago

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

2026-02-26T13:12:57.000Z - 6 months ago

Nuwellis appoints McDonald, Emerson to board of directors

Feb 26, 2026, 8:00 AM EST - 6 months ago

Nuwellis Appoints David A. McDonald and Martin J.

Feb 24, 2026, 8:00 AM EST - 6 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

Feb 17, 2026, 6:00 AM EST - 6 months ago

Nuwellis Slides: Investor presentation

Feb 4, 2026, 7:00 AM EST - 7 months ago

Nuwellis Registration statement: Registration Filing

2026-02-04T11:11:26.000Z - 7 months ago

Nuwellis files to sell 4.28M shares of common stock for holders

Jan 30, 2026, 8:00 AM EST - 7 months ago

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Jan 29, 2026, 4:36 PM EST - 7 months ago

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Jan 29, 2026, 4:35 PM EST - 7 months ago

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Jan 23, 2026, 4:40 PM EST - 7 months ago

Nuwellis Announces Changes to Board of Directors

Jan 6, 2026, 8:15 AM EST - 8 months ago

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Dec 9, 2025, 8:15 AM EST - 9 months ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Dec 4, 2025, 8:15 AM EST - 9 months ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nov 12, 2025, 9:00 AM EST - 10 months ago

Nuwellis Earnings Call Transcript: Q3 2025

Nov 12, 2025, 9:00 AM EST - 10 months ago

Nuwellis Quarterly report: Q3 2025

Nov 12, 2025, 9:00 AM EST - 10 months ago

Nuwellis Earnings release: Q3 2025

Nov 12, 2025, 8:15 AM EST - 10 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nov 10, 2025, 9:00 AM EST - 10 months ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Oct 23, 2025, 9:00 AM EDT - 10 months ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Sep 30, 2025, 8:45 AM EDT - 11 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 18, 2025, 9:00 AM EDT - 12 months ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 17, 2025, 10:16 AM EDT - 12 months ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 9, 2025, 9:00 AM EDT - 1 year ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 4, 2025, 8:15 AM EDT - 1 year ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

ValuePrince Sep. 13 at 4:47 AM

$NUWE ;

0 · Reply

done84 Sep. 12 at 2:42 AM

$NUWE just delist this scam finally!

0 · Reply

TheRipple Sep. 11 at 8:13 PM

$NUWE This is getting good.

0 · Reply

TALENT_ON_LOAN_FROM_GOD Sep. 11 at 5:30 PM

$BDRX $CNSY $NUWE GENIUS 🤡🤡🤡

0 · Reply

Dominicstocks Sep. 11 at 3:11 PM

$NUWE

0 · Reply

thomasirons Sep. 11 at 2:14 PM

$NUWE By not ANOTHER REVERSE SPLIT?.....It would give room for more Shorting.

0 · Reply

Smeagol_the_Trader Sep. 10 at 9:05 PM

$NUWE just patiently loading my position also in $VBIO loading my beautiful bag , lets see which one beat the other in therms of profit %.

0 · Reply

bazooka007 Sep. 10 at 5:53 PM

$NUWE 0,80+ eod and i would be a lucky man

1 · Reply

TheRipple Sep. 10 at 1:15 PM

$NUWE

0 · Reply

Scamstock Sep. 10 at 12:29 PM

$NUWE

0 · Reply

andre82 Sep. 10 at 1:04 AM

$CNSY $BDRX $NUWE One of the short side indicator profiles. Dump it baby! Daddy is ready to cash out. 💰🤑

3 · Reply

DaVinciiKnows Sep. 9 at 11:49 PM

$NUWE adding starter here.

0 · Reply

TheRipple Sep. 9 at 11:37 PM

$CNSY $BDRX $NUWE Throttle me baby.

0 · Reply

Mackie2020 Sep. 9 at 9:13 PM

$CNSY $NUWE $BDRX Top 20 worst performing healthcare stocks the past 10 years - Updated

4 · Reply

tradeflow123 Sep. 9 at 9:04 PM

$NUWE everyone claiming scam is shorting. Don’t fall for it. They are trying to push their agenda!

1 · Reply

TheRipple Sep. 9 at 7:34 PM

$NUWE TBLT much? 👀

0 · Reply

focafoca99 Sep. 9 at 4:24 PM

$NUWE showed gross margin jump to 76% and a cash runway into Q3 2027. https://www.rapidticker.com/news/nuwe-nuwellis-advances-financial-efficiency-strategy-afa99a

0 · Reply

coolcoo Sep. 9 at 1:54 PM

$NUWE $3

2 · Reply

andre82 Sep. 9 at 1:52 PM

$BDRX $NUWE $JAGX $CNSY the ongoing race to $0 😂

1 · Reply

Nuwellis_Inc Sep. 9 at 12:52 PM

$NUWE highlights continued progress under its financial efficiency strategy, including significant gross margin improvement, sustained product quality and supply performance, and further optimization of its cost structure. This strategy continues to advance alongside a strengthened cash position, extending the Company’s operating runway into the third quarter of 2027.

0 · Reply

Russell007xx Sep. 9 at 11:50 AM

$NUWE don’t fall for this scam

0 · Reply

tradeflow123 Sep. 8 at 11:48 PM

$NUWE rip soon! Easy buy…

0 · Reply

Market Cap	2.82M
Revenue (ttm)	8.27M
Net Income (ttm)	-17.52M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-211.85%
Debt to Equity Ratio	0.00

Volume	141,400
Avg Vol	4,272,040
Day's Range	N/A - N/A
Shares Out	3.65M
Stochastic %K	37%
Beta	0.23
Analysts	Strong Buy
Price Target	$11.00